Oncology Venture Sweden AB announced that its Board of Directors has appointed veteran life science executive George O. Elston as its CEO (Chief Executive Officer). Dr. Marie Foegh who has carried the role as CEO and CMO (Chief Medical Officer) since January 2017 will continue as CMO. Mr. Elston is also appointed to the Company's Board of Directors.

Elston will commence his roles immediately. Mr. Elston was most recently the CFO (Chief Financial Officer) of Juniper Pharmaceuticals Inc. where he played a key role in negotiating and executing transformative technology and financing transactions for the women's health therapeutics developer. Mr. Elston is also a member of the board of directors of Celldex Therapeutics Inc. and the Deutsche Bank DBX Trust.